- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/31 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
Patent holdings for IPC class C07K 14/31
Total number of patents in this class: 806
10-year publication summary
|
52
|
52
|
51
|
62
|
48
|
51
|
43
|
52
|
48
|
28
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cytiva BioProcess R&D AB | 312 |
52 |
| Affibody AB | 115 |
35 |
| The University of Chicago | 1429 |
27 |
| Glaxosmithkline Biologicals S.A. | 1651 |
24 |
| Navigo Proteins GmbH | 112 |
22 |
| Roche Sequencing Solutions, Inc. | 662 |
20 |
| Kaneka Corporation | 4610 |
16 |
| New York University | 1750 |
15 |
| Children's Medical Center Corporation | 1891 |
14 |
| Evaxion Biotech A/S | 55 |
13 |
| The Regents of the University of California | 20137 |
10 |
| JSR Corporation | 2532 |
10 |
| GE Healthcare Bio-Sciences AB | 540 |
10 |
| Repligen Corporation | 289 |
10 |
| EMD Millipore Corporation | 648 |
9 |
| The Trustees of the University of Pennsylvania | 4354 |
9 |
| Socpra Sciences et Genie S.E.C. | 201 |
8 |
| GE Healthcare BioProcess R&D AB | 42 |
8 |
| Abvacc, Inc. | 13 |
8 |
| Janssen Pharmaceuticals, Inc. | 437 |
7 |
| Other owners | 479 |